Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

16 Feb 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 16th February 2021 titled ‘Glenmark launches SUTIB (Sunitinib)-priced 96% lower than the innovator brand. Reduces the risk of kidney cancer progression by 58%’ which is self?explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..